ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	35/247	134/7206	5.20947274695e-22
ko04621	NOD-like receptor signaling pathway	34/247	157/7206	1.34859542877e-18
ko04668	TNF signaling pathway	29/247	120/7206	2.29770185572e-17
ko04064	NF-kappa B signaling pathway	25/247	96/7206	6.16655356951e-16
ko04060	Cytokine-cytokine receptor interaction	34/247	191/7206	8.01180117185e-16
ko05164	Influenza A	29/247	167/7206	2.44834201594e-13
ko05140	Leishmaniasis	20/247	75/7206	3.48560811295e-13
ko05161	Hepatitis B	29/247	173/7206	6.2519132273e-13
ko05321	Inflammatory bowel disease (IBD)	17/247	56/7206	2.13719888224e-12
ko05168	Herpes simplex infection	29/247	182/7206	2.36114843597e-12
ko04620	Toll-like receptor signaling pathway	21/247	100/7206	1.34675760405e-11
ko04217	Necroptosis	26/247	178/7206	2.56754450476e-10
ko05162	Measles	21/247	120/7206	5.01296816034e-10
ko04630	Jak-STAT signaling pathway	22/247	132/7206	5.05595193459e-10
ko05152	Tuberculosis	25/247	187/7206	3.85475143438e-09
ko04657	IL-17 signaling pathway	17/247	87/7206	4.16222656739e-09
ko05167	Kaposi's sarcoma-associated herpesvirus infection	25/247	191/7206	6.00722286121e-09
ko04623	Cytosolic DNA-sensing pathway	12/247	41/7206	6.58285095337e-09
ko05145	Toxoplasmosis	20/247	126/7206	7.72179208886e-09
ko04622	RIG-I-like receptor signaling pathway	14/247	62/7206	1.43324825206e-08
ko05133	Pertussis	16/247	87/7206	3.00637882684e-08
ko05323	Rheumatoid arthritis	16/247	89/7206	4.21285244591e-08
ko05160	Hepatitis C	21/247	153/7206	4.55790271741e-08
ko04933	AGE-RAGE signaling pathway in diabetic complications	19/247	135/7206	1.36589772403e-07
ko05144	Malaria	11/247	45/7206	2.22179048422e-07
ko05142	Chagas disease (American trypanosomiasis)	18/247	130/7206	3.79331342207e-07
ko05134	Legionellosis	13/247	74/7206	1.06776756042e-06
ko05166	HTLV-I infection	27/247	292/7206	2.10458798319e-06
ko04659	Th17 cell differentiation	15/247	106/7206	2.76323857793e-06
ko04660	T cell receptor signaling pathway	16/247	124/7206	4.42718320875e-06
ko05340	Primary immunodeficiency	8/247	30/7206	5.17521220434e-06
ko05132	Salmonella infection	14/247	98/7206	5.33596269955e-06
ko04210	Apoptosis	19/247	180/7206	1.14278862259e-05
ko04658	Th1 and Th2 cell differentiation	13/247	96/7206	2.1029869259e-05
ko04650	Natural killer cell mediated cytotoxicity	13/247	97/7206	2.35546556878e-05
ko04672	Intestinal immune network for IgA production	8/247	37/7206	2.77209109967e-05
ko04662	B cell receptor signaling pathway	12/247	88/7206	4.08421825956e-05
ko05169	Epstein-Barr virus infection	18/247	206/7206	0.000232756151093
ko04610	Complement and coagulation cascades	10/247	79/7206	0.000335186408599
ko04062	Chemokine signaling pathway	17/247	201/7206	0.000507546785493
ko04917	Prolactin signaling pathway	10/247	87/7206	0.000732245212609
ko04010	MAPK signaling pathway	23/247	321/7206	0.000745891041296
ko05418	Fluid shear stress and atherosclerosis	15/247	173/7206	0.000835490975132
ko04066	HIF-1 signaling pathway	12/247	123/7206	0.000989643716221
ko04932	Non-alcoholic fatty liver disease (NAFLD)	15/247	182/7206	0.00140237494238
ko04080	Neuroactive ligand-receptor interaction	4/247	423/7206	0.00141310817817
ko05146	Amoebiasis	10/247	99/7206	0.00199140842925
ko04666	Fc gamma R-mediated phagocytosis	11/247	122/7206	0.00299559399608
ko04920	Adipocytokine signaling pathway	9/247	89/7206	0.00328324492326
ko05120	Epithelial cell signaling in Helicobacter pylori infection	9/247	92/7206	0.00410646957238
ko04612	Antigen processing and presentation	8/247	77/7206	0.0046430449774
ko04664	Fc epsilon RI signaling pathway	8/247	77/7206	0.0046430449774
ko04670	Leukocyte transendothelial migration	12/247	151/7206	0.00553952434683
ko04931	Insulin resistance	11/247	137/7206	0.00721288324229
ko05330	Allograft rejection	4/247	24/7206	0.00833590669636
ko05203	Viral carcinogenesis	18/247	277/7206	0.00998680404671
ko04145	Phagosome	12/247	162/7206	0.0128453675621
ko04915	Estrogen signaling pathway	10/247	131/7206	0.0142428085695
ko05320	Autoimmune thyroid disease	4/247	29/7206	0.0163054208393
ko05310	Asthma	3/247	17/7206	0.018952146591
ko04218	Cellular senescence	12/247	177/7206	0.0202205238179
ko05131	Shigellosis	7/247	82/7206	0.021889137771
ko05332	Graft-versus-host disease	3/247	18/7206	0.0221785164636
ko04940	Type I diabetes mellitus	4/247	32/7206	0.0227974702636
ko05143	African trypanosomiasis	4/247	32/7206	0.0227974702636
ko05212	Pancreatic cancer	7/247	83/7206	0.0232325335282
ko04624	Toll and Imd signaling pathway	5/247	49/7206	0.0253926694796
ko05222	Small cell lung cancer	7/247	89/7206	0.0324991997917
ko05150	Staphylococcus aureus infection	4/247	36/7206	0.0335984905123
ko04930	Type II diabetes mellitus	5/247	54/7206	0.0367388160904
ko01522	Endocrine resistance	9/247	124/7206	0.0389441952852
ko04115	p53 signaling pathway	6/247	74/7206	0.0406903684547